Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis
Author(s) -
Christopher J. Cooper,
Timothy P. Murphy,
Donald E. Cutlip,
Kenneth Jamerson,
William L. Henrich,
Diane Reid,
David Cohen,
Alan H. Matsumoto,
Michael W. Steffes,
Michael R. Jaff,
Martin R. Prince,
Eldrin F. Lewis,
Katherine R. Tuttle,
Joseph I. Shapiro,
John H. Rundback,
Joseph M. Massaro,
Ralph B. D’Agostino,
Lance D. Dworkin
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1310753
Subject(s) - medicine , renal artery stenosis , cardiology , hazard ratio , interquartile range , myocardial infarction , kidney disease , stroke (engine) , renal artery , stent , blood pressure , clinical endpoint , renal function , heart failure , stenosis , coronary artery disease , adverse effect , randomized controlled trial , kidney , confidence interval , mechanical engineering , engineering
Atherosclerotic renal-artery stenosis is a common problem in the elderly. Despite two randomized trials that did not show a benefit of renal-artery stenting with respect to kidney function, the usefulness of stenting for the prevention of major adverse renal and cardiovascular events is uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom